See more : 5paisa Capital Limited (5PAISA.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Sumitomo Chemical India Limited (SUMICHEM.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sumitomo Chemical India Limited, a leading company in the Agricultural Inputs industry within the Basic Materials sector.
- GFJ ESG Acquisition I SE (GFJ1.DE) Income Statement Analysis – Financial Results
- Cartier Resources Inc. (ECR.V) Income Statement Analysis – Financial Results
- Nissin Corporation (9066.T) Income Statement Analysis – Financial Results
- KNC Laboratories Co., Ltd. (6568.T) Income Statement Analysis – Financial Results
- Vonex Limited (VN8.AX) Income Statement Analysis – Financial Results
Sumitomo Chemical India Limited (SUMICHEM.NS)
About Sumitomo Chemical India Limited
Sumitomo Chemical India Limited engages in the manufacture and sale of household and public health insecticides, agricultural pesticides, and animal nutrition products in India and internationally. It operates through two segments, Agro Chemicals and Others. The company offers crop protection products, such as insecticides, herbicides, fungicides, and miticides; animal nutrition and plant growth regulators; fumigants and rodenticides; weedicides; and biological products. It also exports its products. The company was incorporated in 2000 and is headquartered in Mumbai, India. Sumitomo Chemical India Limited is a subsidiary of Sumitomo Chemical Company Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28.18B | 35.11B | 30.40B | 26.28B | 23.98B | 21.83B | 18.91B | 7.96B | 7.64B |
| Cost of Revenue | 17.99B | 22.71B | 19.17B | 16.62B | 16.14B | 14.65B | 12.45B | 5.32B | 5.14B |
| Gross Profit | 10.19B | 12.40B | 11.24B | 9.66B | 7.84B | 7.18B | 6.46B | 2.65B | 2.50B |
| Gross Profit Ratio | 36.17% | 35.33% | 36.96% | 36.76% | 32.69% | 32.87% | 34.18% | 33.23% | 32.76% |
| Research & Development | 13.42M | 11.25M | 12.03M | 7.84M | 6.65M | 6.24M | 13.65M | 1.15M | 5.05M |
| General & Administrative | 2.52B | 187.57M | 156.78M | 291.84M | 227.45M | 224.23M | 155.27M | 73.67M | 62.20M |
| Selling & Marketing | 387.14M | 1.21B | 1.31B | 1.06B | 986.62M | 841.67M | 872.19M | 403.29M | 717.22M |
| SG&A | 2.90B | 1.39B | 1.46B | 1.35B | 1.21B | 1.07B | 1.03B | 476.96M | 779.42M |
| Other Expenses | 0.00 | 448.51M | 12.67M | 12.04M | 47.77M | 36.53M | 22.41M | 12.16M | 13.89M |
| Operating Expenses | 2.92B | 6.26B | 5.65B | 5.01B | 4.84B | 4.54B | 4.18B | 1.59B | 1.44B |
| Cost & Expenses | 20.87B | 28.96B | 24.82B | 21.62B | 20.97B | 19.19B | 16.63B | 6.91B | 6.57B |
| Interest Income | 589.97M | 249.35M | 103.54M | 99.52M | 39.20M | 37.26M | 29.49M | 44.56M | 34.27M |
| Interest Expense | 56.93M | 53.94M | 47.18M | 40.97M | 55.13M | 36.50M | 28.36M | 9.62M | 4.12M |
| Depreciation & Amortization | 621.89M | 518.78M | 448.14M | 465.83M | 409.70M | 278.04M | 237.31M | 69.47M | 74.43M |
| EBITDA | 5.71B | 7.12B | 6.29B | 5.07B | 3.15B | 2.91B | 2.50B | 1.14B | 1.15B |
| EBITDA Ratio | 20.26% | 20.26% | 20.07% | 19.68% | 14.34% | 13.39% | 13.37% | 14.71% | 15.18% |
| Operating Income | 7.57B | 6.15B | 5.57B | 4.44B | 2.97B | 2.69B | 2.28B | 1.05B | 1.07B |
| Operating Income Ratio | 26.87% | 17.51% | 18.31% | 16.88% | 12.38% | 12.31% | 12.06% | 13.23% | 13.98% |
| Total Other Income/Expenses | -2.54B | -2.99B | -3.15B | -2.88B | -399.70M | -96.63M | -70.44M | 10.17M | 2.14M |
| Income Before Tax | 5.03B | 6.54B | 5.76B | 4.53B | 2.67B | 2.60B | 2.21B | 1.06B | 1.07B |
| Income Before Tax Ratio | 17.85% | 18.63% | 18.94% | 17.25% | 11.12% | 11.90% | 11.69% | 13.36% | 14.01% |
| Income Tax Expense | 1.33B | 1.52B | 1.52B | 1.08B | 618.26M | 940.47M | 758.48M | 426.21M | 424.24M |
| Net Income | 3.70B | 5.02B | 4.24B | 3.45B | 2.05B | 1.66B | 1.45B | 637.38M | 646.25M |
| Net Income Ratio | 13.11% | 14.30% | 13.93% | 13.14% | 8.54% | 7.60% | 7.67% | 8.01% | 8.46% |
| EPS | 7.40 | 10.06 | 8.49 | 6.92 | 4.10 | 3.32 | 2.91 | 1.28 | 1.29 |
| EPS Diluted | 7.40 | 10.06 | 8.49 | 6.92 | 4.10 | 3.32 | 2.91 | 1.28 | 1.29 |
| Weighted Avg Shares Out | 499.15M | 499.15M | 499.15M | 499.15M | 499.15M | 499.15M | 499.15M | 499.15M | 499.15M |
| Weighted Avg Shares Out (Dil) | 499.15M | 499.15M | 499.15M | 499.15M | 499.15M | 499.15M | 499.15M | 499.15M | 499.15M |
Source: https://incomestatements.info
Category: Stock Reports